Fight The Fakes

Speak up about fake medicines.

Campaign Updates

Launch of Global Study on Fake Medicines, from Laboratory and Field Innovations to Policy Perspectives

Pharmaceutical Security Institute (PSI) |

Launch of Global Study on Fake Medicines, from Laboratory and Field Innovations to Policy Perspectives


The American Journal of Tropical Medicine and Hygiene released on 20 April 2015 a special supplement that includes 17 articles on falsified and substandard medicines. This special issue, titled, “The Global Pandemic of Falsified Medicines: Laboratory and Field Innovations and Policy Perspectives,” covers a range of findings on the state of substandard medicines around the world. Several articles suggest policy interventions, including an international framework and the adoption of stricter national laws against drug counterfeiting.

A full list of articles along with press and explanatory materials can be found on the ASTMH website.The Press Release is available here.

The study titled Counterfeit Drug Penetration into Global Legitimate Medicine Supply Chains: A Global Assessment (Authors: Tim K. Mackey, Bryan A. Liang, Peter York and Thomas Kubic) by University of California, San Diego -School of Medicine and the Pharmaceutical Security Institute, assesses counterfeit reports involving the legitimate supply chain using 2009–2011 data from the Pharmaceutical Security Institute Counterfeit Incident System (PSI CIS) database that uses both open and nonpublic data sources.

This study has been supported by Fight the Fakes partners International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and Pharmaceutical Security Institute (PSI). The abstract of the study can be found below:

 

Counterfeit medicines are a global public health risk. We assess counterfeit reports involving the legitimate supply chain using 2009–2011 data from the Pharmaceutical Security Institute Counterfeit Incident System (PSI CIS) database that uses both open and nonpublic data sources. Of the 1,510 identified CIS reports involving counterfeits, 27.6% reported China as the source country of the incident/detection. Further, 51.3% were reported as counterfeit but the specific counterfeit subcategory was not known or verifiable. The most prevalent therapeutic category was anti-infectives (21.1%) with most reports originating from health-related government agencies. Geographically, Asian and Latin American regions and, economically, middle-income markets were most represented. A total of 127 (64.8%) of a total of 196 countries had no legitimate supply chain CIS counterfeit reports. Improvements in surveillance, including detection of security breaches, data collection, analysis, and dissemination are urgently needed to address public health needs to combat the global counterfeit medicines trade.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

About the American Journal of Tropical Medicine and Hygiene
Continuously published since 1921, AJTMH is the peer-reviewed journal of the American Society of Tropical Medicine and Hygiene, and the world’s leading voice in the fields of tropical medicine and global health. AJTMH disseminates new knowledge in fundamental, translational, clinical and public health sciences focusing on improving global health.

blog comments powered by Disqus

Back to List

Of the 1mil deaths per year due to #malaria, 200,000 could be avoided if patients weren't treated with #fakemeds

2011: European Customs retained 27.5 million #fakemeds

#Fakemeds seized in Le Havre in May 2013 were hidden in sachets of tea

#fakemeds are 10% to 30% of global medicine: less than 1% in some countries, +30% in parts of Africa Asia & Latin America

Poisons found in #fakemeds include mercury, rat poison, boric acid, paint & antifreeze

In 2013 1.2 million sachets of #fakemeds were seized in Le Havre, France. The biggest seizure in the #EU

Decades of fighting #malaria could be put at risk by #fakemeds on the market

#DidYouKnow? Possession of #fakemeds is illegal, not just production or sale

20% of all #malaria deaths worldwide can be directly associated with the use of #fakemeds

700,000 people die because of #fakemeds to treat #malaria & #TB each year

Up to 40% of the drug supply of some countries in Africa could be #fakemeds

#fakemeds could be up to 15% of medicines in circulation worldwide

1 out of 4 counterfeit products intercepted by EU customs in 2011 were #fakemeds

60% of all spam offers medicine- its an inexpensive way for #counterfeiters to target you with #fakemeds.

Up to 30% of medicines in developing countries are #fakemeds

India may have as much as 12-25% of their supply contaminated with substandard and #fakemeds

In 2013, Operation #Biyela seized 550 million doses of illicit medicine in #Africa

In the US only 4% of online pharmacies appear to be in compliance with pharmacy laws & practice standards

#Fakemeds: 32% have no active ingredients, 40% have incorrect ingredients & dose, 8.5% contain dangerous contaminants

1 medicine in 2 purchased on internet sites that conceal their physical address is a #fakemed

From antibiotics to pain relievers, more than 500 versions of fake #pharmaceutical products are circulating #fakemeds

NIH 2012 study of 7 countries in southeast Asia reveals that 36% of #antimalarials are #fakemeds

Both branded and generic products are subject to counterfeiting

#Fakemeds seized during #Biyela? Antibiotics, painkillers, meds for high blood pressure & diabetes

#DidYouKnow? 96% of online pharmacies operate illegally

More than 50% of medicine sold worldwide from illegal online sources are #fakemeds

.@INTERPO_HQ L Operation #PangeaVI seized 9.8 million illegal & counterfeit drugs #fakemeds

#Fakemeds can contain no active ingredients at all – a direct threat to patients that need treatment

On internet sites that conceal their physical address 50% of the drugs are #fakemeds

.@UNODC estimates the market value of fake #antimalarials at over US$400mil in west Africa alone

Every therapeutic class of pharmaceutical product has been the subject of #counterfeiting

Criminals trafficking #fakemeds make profits 10x more than those trafficking illicit drugs

30% of countries have little or no regulation to effectively combat #fakemeds

123 countries are impacted by #fakemeds

36% of #anti-malarial drugs in #SoutheastAsia are #fakemeds

In 2013 US authorities published warning of fake #diabetes meds—ineffective & dangerous for patients